This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

“It requires a nice healthy demand to ensure that for each of the generic companies, it’s going to be worth their while,” says Bekker. “We are all hoping that governments [across sub-Saharan Africa] are writing the generic product into…